Skip to search formSkip to main contentSkip to account menu

epoetin beta

Known as: beta epoetin, EPOB, recombinant 1-165-erythropoietin glycoform beta 
A recombinant therapeutic agent that is chemically identical to or similar to the endogenous cytokine human erythropoietin (EPO). Produced primarily… 
National Institutes of Health

Related topics

Related topics

8 relations
B-Cell ActivationErythropoietin ReceptorHematopoiesis InductionReceptor Activation Process

Broader (2)

ErythropoietinRecombinant Proteins

Narrower (1)

Recormon

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Prevalencia de anemia y su manejo clínico en la enfermedad renal crónica estadios 3-5 no en diálisis en Cataluña: estudio MICENAS I
Introduccion: La anemia es una complicacion frecuente de la enfermedad renal cronica (ERC). El objetivo de este estudio fue… 
2014
2014
Molecular recognition of epothilones by microtubules and tubulin dimers revealed by biochemical and NMR approaches.
The binding of epothilones to dimeric tubulin and to microtubules has been studied by means of biochemical and NMR techniques. We… 
Review
2012
Review
2012
New anemia therapies: translating novel strategies from bench to bedside.
Recombinant human erythropoietin (epoetin) has been available for the treatment of renal anemia for more than 20 years, and… 
Review
2012
Review
2012
Epoetin Beta
SummaryAbstractEpoetin beta (NeoRecormon®) is a recombinant form of erythropoietin. It increases reticulocyte counts, haemoglobin… 
2006
2006
Epoetin beta (NeoRecormon) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy: a meta-analysis.
BACKGROUND Anaemia is a common complication of chemotherapy (CT), including both non-platinum (Pt)-based as well as Pt-based CT… 
2004
2004
Role of epoetin in the management of anaemia in patients with lung cancer.
2004
2004
Epoetin beta (NeoRecormon) corrects anaemia in patients with hormone-refractory prostate cancer and bone metastases.
BACKGROUND Severe anaemia is common in patients with metastatic, hormone-refractory prostate cancer (HRPC). PATIENTS AND… 
2003
2003
PRCA in a patient treated with epoetin beta.
Sir, In patients treated with recombinant human erythropoietin for anaemia of chronic renal failure, pure red-cell aplasia Fig 1… 
Highly Cited
2001
Highly Cited
2001
Efficacy of epoetin beta on hemoglobin, quality of life, and transfusion needs in patients with anemia due to hormone-refractory prostate cancer--a randomized study.
OBJECTIVE Erythropoietin is shown to be an effective treatment for anemia in various types of cancers, however only limited… 
1992
1992
Epoetin enhances erythropoiesis in normal men undergoing repeated phlebotomies
Epoetin may enhance autologous blood donation, but efficacy and dose response have not been established. This multicenter, double… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)